Patient Guide 14 min read May 19, 2026

Andropause and Testosterone Replacement Therapy: A Houston Patient’s Guide

Andropause is the gradual decline in male hormonal function with age. For men experiencing symptoms, TRT can be a meaningful clinical tool. A Houston physician’s guide.

You are a man in your mid-40s, or your 50s, or your 60s. Over the past several years, things have changed — not dramatically, not all at once, but cumulatively in ways that are hard to ignore. Your energy is lower. Your workouts produce less than they used to. Body fat has shifted. Libido is not what it was. You are sleeping but waking up tired. Maybe you have noticed a quiet flatness — not depression exactly, but a missing edge.

If this describes you, what you are likely experiencing is the gradual decline in male hormonal function that medical literature increasingly calls andropause, or late-onset hypogonadism, or simply low testosterone. It is real. It is well-documented. And in many cases, it is treatable.

This article walks through what andropause actually is, how it differs from female menopause, who is a candidate for testosterone replacement therapy, what to expect from treatment, and how Houston patients should evaluate their options. We are The Tide, a peptide-focused medical clinic in Houston, Texas, and TRT is a core part of our men’s hormone health service.

What andropause actually is

Andropause is the gradual age-related decline in testosterone production in men. Unlike female menopause, which is a defined biological event with a clear endpoint (the cessation of menstruation), andropause is a slow physiologic process that unfolds over decades. Testosterone production peaks in a man’s early 20s and declines gradually thereafter — typically by about 1 to 2 percent per year after age 30. For some men, the decline produces no meaningful symptoms even into their 70s and 80s. For others, the decline crosses a clinical threshold somewhere in their 40s or 50s, and the symptoms become significant enough to affect quality of life.

The term andropause is somewhat imprecise. It implies a male equivalent of menopause, which is not quite accurate — there is no single moment of hormonal change, and not every man experiences clinically meaningful decline. The more precise medical terms are late-onset hypogonadism or age-related testosterone deficiency. In patient-facing conversations, andropause has stuck because it captures the lived experience even if the biology is more gradual.

The symptoms of andropause overlap significantly with the symptoms of other conditions, which is part of why diagnosis requires both labs and clinical evaluation. The classic presentation includes fatigue, reduced exercise tolerance, decreased libido, erectile dysfunction or weakened erections, mood changes (irritability, low motivation, “missing edge”), cognitive complaints (brain fog, reduced focus), sleep disruption, body composition changes (gain in central fat, loss of muscle mass), decreased bone density, and decreased physical strength.

Many of these symptoms can also reflect other conditions — depression, thyroid dysfunction, sleep apnea, chronic stress, poor lifestyle inputs, or other medical issues. The clinical work is to distinguish between low testosterone as the primary problem and low testosterone as a secondary finding alongside something else.

How andropause differs from menopause

Several important differences distinguish male hormonal decline from female menopause.

Timing and progression. Menopause is typically completed within a few years (the transition from perimenopause through the final menstrual period and into postmenopause). Andropause is gradual over decades.

Universality. Virtually all women who live long enough experience menopause and its hormonal changes. Not all men experience clinically meaningful testosterone decline. Genetics, lifestyle, body composition, sleep, stress, and other factors significantly affect whether a given man’s testosterone declines enough to produce symptoms.

Diagnosis. Menopause is largely a clinical diagnosis (cessation of menstruation for 12 months, sometimes supported by FSH measurement). Andropause requires both clinical symptoms and laboratory confirmation of low testosterone — the diagnosis is not made on symptoms alone or labs alone.

Treatment goal. Female hormone therapy aims to manage symptoms and reduce certain health risks (bone loss, cardiovascular risk in certain populations) without restoring premenopausal hormone levels. Testosterone replacement in men more often does aim to restore physiologic levels — typically targeting the middle-to-upper end of the normal range for a healthy adult man — though the principles of individualization still apply.

These differences affect how the medicine is practiced. The decision to start TRT is more nuanced than the decision to start female hormone therapy because the population of candidates is less universal and the diagnostic thresholds matter more.

Who is a candidate for testosterone replacement therapy

A man is a candidate for TRT when two conditions are both met: laboratory evidence of low testosterone, and clinical symptoms consistent with low testosterone. Either alone is not sufficient. Low labs without symptoms generally do not justify treatment. Symptoms without lab confirmation may reflect something other than low testosterone.

The laboratory threshold. Total testosterone is measured on accurate morning bloodwork — timing matters because testosterone levels follow a daily rhythm, peaking in the morning and declining through the day. A morning total testosterone reading consistently below approximately 300 ng/dL, confirmed on repeat testing, generally meets the laboratory criterion for hypogonadism. Free testosterone (the bioavailable fraction) and sex hormone binding globulin (SHBG) provide additional clinical detail — some men with total testosterone in the “normal” range have low free testosterone and meaningful symptoms because of elevated SHBG. A comprehensive evaluation looks at the full picture.

The clinical symptoms. The symptoms listed above — fatigue, low libido, erectile changes, mood changes, body composition changes, sleep disruption, cognitive complaints — are the symptoms that align with low testosterone. Their presence alongside lab confirmation strengthens the case for treatment. Their absence, even with low labs, makes the decision more nuanced.

The differential diagnosis. Before attributing symptoms to low testosterone, other causes should be evaluated. Thyroid dysfunction, depression, sleep apnea, anemia, chronic illness, medication side effects, and lifestyle factors can all produce similar symptoms. A thorough clinical evaluation considers and rules out these alternatives — or, more accurately, considers whether they exist alongside low testosterone and how each contributes.

The contraindications. TRT is not appropriate for all candidates. Active prostate cancer, untreated severe sleep apnea, severe untreated heart failure, and several other conditions are absolute or relative contraindications. Personal and family medical history matters. A clinic that prescribes TRT without screening for these is not doing the work the medicine requires.

What TRT actually involves

TRT is the administration of testosterone — typically through injection, less commonly through transdermal gel, pellet, or other delivery methods — to restore testosterone levels to a target range and address the symptoms of deficiency.

Injectable testosterone is the most common form. Typically testosterone cypionate or testosterone enanthate, administered subcutaneously or intramuscularly, either weekly or twice weekly. Injection-based protocols allow precise dosing and flexible adjustment. Most modern protocols use smaller, more frequent doses (twice weekly subcutaneous) rather than the larger, less frequent doses (biweekly intramuscular) that defined earlier practice — the smaller, more frequent approach produces more stable levels and reduces side effects.

Testosterone gel is applied to the skin daily and absorbed transdermally. Gel has the advantage of providing daily steady-state delivery without injection. The disadvantage is that absorption varies between patients and across days, dosing flexibility is more limited, and there is some risk of transfer to others (partners, children) through skin contact.

Testosterone pellets are bioidentical testosterone implants placed under the skin that release hormone steadily over three to six months. Pellets eliminate the need for daily or weekly dosing but are not the right delivery method for every patient — they cannot be easily removed if a dose adjustment is needed, and the steady-state release suits some patients better than others.

Supporting medications. TRT is not always testosterone alone. Many protocols include HCG (human chorionic gonadotropin), which preserves testicular function and fertility by stimulating natural testosterone production alongside the replacement. Some protocols include aromatase inhibitors like anastrozole when estradiol levels rise too high in response to testosterone administration. The specifics depend on the patient — younger men concerned about fertility benefit from HCG inclusion, men with significantly elevated estradiol response benefit from aromatase management, and so on.

Our TRT protocols at The Tide are designed individually based on the patient’s labs, goals, fertility considerations, and clinical context. We do not run a single template protocol.

What to expect from treatment

The improvements from properly prescribed TRT generally follow a predictable timeline, though individual experience varies.

Weeks 1 to 4. Some patients notice improvements in mood, motivation, and energy within the first few weeks. These tend to be the earliest changes because the central nervous system responds quickly to testosterone restoration. Many patients report sleeping better, feeling more present, and having a return of some of the “missing edge” that defined the symptomatic period.

Months 1 to 3. Libido and sexual function improvements typically emerge in this window. Recovery from training improves. Energy levels stabilize. Body composition begins to shift — typically with reduced body fat and the beginning of muscle mass restoration if the patient is also training appropriately.

Months 3 to 6. The full effects of therapy become apparent. Body composition changes are more visible. Strength improvements compound. Cardiovascular fitness often improves. Most patients have settled into a stable response and are doing routine follow-up rather than active titration.

Beyond 6 months. Maintenance phase. Periodic labs and clinical follow-up. Dose adjustments as needed based on response and any changes in clinical picture.

Patients who do best with TRT are typically those who pair the medicine with the foundational work — consistent training (especially resistance training), adequate protein intake, sleep, stress management, and overall metabolic health. TRT is a meaningful tool, but it is not a replacement for the inputs that determine body composition, energy, and overall function.

What good TRT monitoring looks like

TRT is not a fire-and-forget prescription. The monitoring schedule matters significantly for both safety and effectiveness.

Baseline labs include comprehensive hormone panel (total and free testosterone, estradiol, LH, FSH, prolactin, SHBG), PSA in age-appropriate patients, complete blood count with hematocrit, comprehensive metabolic panel, lipid panel, and other markers as clinically indicated.

Follow-up labs are typically run at 6-8 weeks after starting therapy or after a dose change, then quarterly through the first year, then every six months in maintenance. The 6-8 week timing is important because it allows enough time for the protocol to reach steady state but is early enough to adjust before any issues compound.

Hematocrit deserves special attention in TRT monitoring. Testosterone can stimulate red blood cell production, and significantly elevated hematocrit (polycythemia) is the most common adverse effect of TRT. It is managed clinically through dose adjustment, hydration, and occasionally therapeutic phlebotomy. A clinic that does not check hematocrit regularly is missing the most important safety parameter in TRT.

PSA monitoring matters in age-appropriate patients. TRT does not cause prostate cancer (this is one of the older concerns that modern evidence has substantially refined), but it is appropriate to monitor PSA and to manage prostate health proactively in older men on testosterone.

Clinical follow-up — symptoms, energy, mood, libido, body composition, training response — is as important as labs. Numbers on a page do not tell the full story. Our advanced labs service integrates biomarker tracking with clinical conversation so that protocols can be refined based on the complete picture.

TRT and peptide therapy together

Many men on TRT also benefit from peptide therapy as part of a comprehensive optimization protocol. The two categories are complementary rather than competitive.

The most common pairing is TRT with a growth hormone-supporting peptide such as sermorelin, ipamorelin, or CJC-1295. Testosterone addresses the androgen deficiency. The GH-supporting peptide supports the recovery, sleep, and body composition changes that come from age-related decline in growth hormone pulsatility — a problem TRT alone does not fully address.

Other peptide additions depend on the patient. Men with chronic injuries or recovery issues may benefit from BPC-157 or TB-500 alongside TRT. Men with significant metabolic resistance may benefit from a GLP-1 medication alongside TRT — body composition gains from TRT compound when metabolic resistance is also addressed. Men with sexual function concerns that persist on TRT may benefit from PT-141 or other peptides that target central nervous system pathways involved in desire and arousal.

Coordination matters. A clinician designing a combined protocol needs to think about both categories at once, not in isolation. Our peptide therapy service works alongside hormone optimization rather than in competition with it.

What Houston patients should ask before starting TRT

The Houston metro area has dozens of clinics offering testosterone therapy. Quality varies enormously. A few questions distinguish thorough clinics from transactional ones:

What labs are you running before prescribing? If the answer is just total testosterone, you are not getting the comprehensive baseline that proper TRT requires. A real evaluation includes total and free testosterone, estradiol, LH, FSH, SHBG, prolactin, PSA where age-appropriate, hematocrit, comprehensive metabolic panel, and other markers as indicated by your medical history.

How will you monitor me on therapy? The answer should include lab follow-up at 6-8 weeks and quarterly through the first year, hematocrit monitoring, estradiol management when needed, and clinical follow-up on symptoms and quality of life. “We will refill your prescription monthly” is not a monitoring plan.

How do you handle fertility considerations? If you are younger and may want children in the future, TRT can suppress your natural testosterone and fertility. A thorough clinic discusses HCG inclusion, fertility-preserving protocols, and the realistic timeline of recovery if you decide to come off therapy.

What are the contraindications you screen for? Active prostate cancer, untreated severe sleep apnea, severe heart failure, and several other conditions affect whether TRT is appropriate. A clinic that doesn’t ask is missing important safety information.

How do you decide between injection, gel, and pellets? If the clinic offers only one delivery method, that is a limitation. Each method has trade-offs. Your clinical picture, lifestyle, and preferences should inform the choice.

What is your approach to ancillary medications? HCG, anastrozole, and other supporting medications are part of modern TRT for many patients. A clinic that doesn’t discuss them — or that gives every patient the same template regardless of clinical picture — is not designing individualized protocols.

The Houston context

Houston has a wide range of TRT clinics, from traditional endocrinology practices to medspas that added testosterone to their menu to online operations that prescribe by questionnaire. The quality runs the full spectrum.

For Houston patients, the practical implication is that you have options — and you should evaluate them. The clinic adjacent to the Texas Medical Center, the standalone men’s clinic in your neighborhood, and the online operation that ships testosterone after a five-minute video call are not equivalent. The quality of evaluation, the monitoring rigor, the willingness to individualize, and the willingness to say “TRT is not the right tool for you” if that is the honest answer all vary significantly.

The Tide is located adjacent to the Texas Medical Center, and our approach to TRT reflects the principles that govern our peptide therapy work: comprehensive evaluation, individualized protocols, multiple delivery methods, ongoing monitoring, and honest discussion of risks and benefits. We do not prescribe testosterone by questionnaire. We do not ship vials after a five-minute call. The work requires more than that.

How to think about whether TRT is right for you

If you have the symptoms described above and they are affecting your quality of life, the question worth asking is whether the underlying cause is hormonal — and whether testosterone replacement is the right tool to address it. That answer requires labs and a clinical conversation. It cannot be made from an article.

The men who do best on TRT tend to share a few traits. They have specific symptoms they want addressed. They have labs that confirm a deficiency consistent with their symptoms. They are willing to do the work that good clinical care requires — labs, follow-up appointments, protocol adjustments, attention to the foundational pieces (training, nutrition, sleep). They want to understand what they are taking and why.

The men who tend to be disappointed by TRT are those who expected it to fix everything, those who started without adequate evaluation, those whose protocol was templated rather than individualized, or those who skipped the foundational work. In most of those cases, the disappointment was not the fault of testosterone itself. It was the structure around it.

If you are in Houston and considering TRT, the right next step is a comprehensive consultation with a clinician who specializes in male hormone optimization — someone who will take the time to understand your symptoms, evaluate your medical context, run appropriate baseline labs, design an individualized protocol, and follow up to see whether it is working.

About The Tide

The Tide is a peptide-focused medical clinic in Houston, Texas, located adjacent to the Texas Medical Center. Our men’s hormone health service offers comprehensive testosterone replacement therapy with full baseline labs, individualized protocols, multiple delivery methods, structured monitoring, and integration with peptide therapy where clinically appropriate. We prescribe injectable TRT, transdermal preparations, and hormone pellets based on what fits each patient. For deeper reading on how we approach the work, see our clinical standards.

Keep reading

Related articles.

Opening Soon!
This is default text for notification bar